Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Pentanoic acid, 2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[ | 56124-62-0 | MFCD01939322 | 99.6% | C34H36F3NO13 | 10MG
SDP

Supplier:  Medchemexpress LLC HY1377210MG

Encompass_Preferred

Valrubicin is an anthracycline chemotherapy agent provided for research use. It inhibits TPA- and PDBu-induced protein kinase C (PKC) activation with reported IC50 values of 0.85 μM and 1.25 μM, and demonstrates antitumor and anti-inflammatory activity in preclinical studies.

  • Inhibits TPA- and PDBu-induced protein kinase C activation (IC50 0.85 μM and 1.25 μM).
  • Exhibits antitumor and anti-inflammatory activity in preclinical models.
  • Provided as a research-grade small molecule for biochemical and cellular assays.
  • High purity suitable for analytical applications (purity 99.6% by LCMS).
  • Available in small pack sizes suitable for assay development and reference standards.

Catalog No. 50-187-2957


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.